| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 07/02/2009 | US20090170832 HETEROCYCLIC COMPOUNDS HAVING TYPE I 11beta HYDROXYSTEROID DEHYDROGENASE INHIBITORY ACTIVITY |
| 07/02/2009 | US20090169479 Compounds Comprising Short Aminoalcohol Chains and Metal Complexes for Medical Imgaing |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | CN101468972A Metal salts of 2'-(1H-tetraz0l-5-yl)-1,1'-biphenyl-4-carboxaldehyde |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553872 Compounds and compositions for delivering active agents |
| 06/30/2009 | US7553861 Type-2 diabetes |
| 06/25/2009 | WO2009077371A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
| 06/25/2009 | US20090163502 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
| 06/25/2009 | CA2708228A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists |
| 06/24/2009 | CN101463017A Method for synthesizing 5-nitramino tetrazole |
| 06/23/2009 | US7550448 Therapeutic compounds |
| 06/18/2009 | WO2009076173A2 Fluorinated tripeptide hcv serine protease inhibitors |
| 06/18/2009 | WO2009075080A1 Fluoroalkylsulfide derivative and pest control agent |
| 06/18/2009 | US20090156655 Used to treat diabetic and other glucagon related metabolic disorders such as obesity, hyperglycemia, atherosclerosis, ischemic heart disease, stroke, neuropathy, and wound healing; (4-[1-(2,6-Dimethyl-4'-trifluoromethyl-biphenyl-4-yloxy)-3,3-dimethyl-butyl]-N-(1H-tetrazol-5-ylmethyl)-benzamide |
| 06/18/2009 | US20090156585 Organic compounds |
| 06/18/2009 | US20090155203 Thrombopoietin mimetics |
| 06/17/2009 | EP2068869A2 Novel imidazothiazoles and imidazoxazoles |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
| 06/16/2009 | US7547685 Therapeutic substituted pyrrolidone compounds |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496490C Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases |
| 06/09/2009 | US7544811 Di- and multifunctional monomers for producing tetrazole based polymers |
| 06/04/2009 | WO2009069833A1 Aza compounds and production method thereof, and metal complexes as mri contrast agents. |
| 06/04/2009 | WO2009068557A1 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators |
| 06/04/2009 | WO2009068509A1 Novel benzamide derivatives useful as potassium channel modulators |
| 06/04/2009 | US20090143592 Glucagon Antagonists/Inverse Agonists |
| 06/04/2009 | US20090143405 1-{[1-(2,6-dimethylphenyl)-1H-tetrazol-5-yl]phenylmethyl}-4-(3-phenylallyl)piperazine; G-protein coupled receptor antagonist; antidepressant, anxiolitic agent, obesity |
| 06/04/2009 | US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors |
| 06/03/2009 | CN101444496A Compounds for the treatment of metabolic disorders |
| 06/02/2009 | US7541467 N,N,N',N'-tetrakis(2-quinolylmethyl)ethylenediamine; reacting with Zinc ions; inhibition of photoinduced electron transfer (PET) |
| 06/02/2009 | US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases |
| 06/02/2009 | US7541375 Azole derivatives and pharmaceutical compositions containing them |
| 05/28/2009 | WO2009065850A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/27/2009 | EP2061760A1 Benzo-fused compounds for use in treating metabolic disorders |
| 05/27/2009 | EP0934287B1 Heterocyclic esters and amides |
| 05/27/2009 | CN101443346A Hybrid compounds based on polyol(s) and at least one other molecular entity, polymer or otherwise, especially of the polyorganosiloxane type, method for the preparation thereof, and applications of th |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538133 Benzimidazole derivatives, their production and use |
| 05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2291782C Production of mono and 1,7-bis-n-hydroxyalkyl-cyclene and lithium salt complexes |
| 05/22/2009 | WO2009065081A2 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions |
| 05/22/2009 | WO2009065070A2 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions |
| 05/22/2009 | CA2705761A1 Super-oxide dismutase mimetics |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/21/2009 | US20090130117 Substituted Tetrazole Compounds and Uses Thereof |
| 05/20/2009 | CN101437804A Dibenzyl amine compounds and derivatives |
| 05/20/2009 | CN101437803A Dibenzyl amine derivatives as CETP inhibitors |
| 05/19/2009 | US7534894 2-[(4'-{[5-(2-chlorophenyl)-2-(trifluoromethyl)-3-furoyl]amino}-1,1'-biphenyl-3-yl)oxy]-3-phenylpropanoic acid ; thrombosis, atrial fibrillation, pulmonary fibrosis, stroke, myocardial ischemia, atherosclerotic plaque formation, chronic obstructive pulmonary disease, or renal fibrosis |
| 05/19/2009 | CA2336634C Antiviral macrocyclic compounds |
| 05/19/2009 | CA2211381C Compounds with growth hormone releasing properties |
| 05/14/2009 | WO2009061681A2 Antagonists of pgd2 receptors |
| 05/14/2009 | US20090123538 Angiotensin II Receptor Antagonists |
| 05/13/2009 | EP2057132A2 Process for the preparation of the angiotensin ii antagonist valsartan |
| 05/13/2009 | EP2057131A1 Method of dynamic nuclear polarisation (dnp) and compounds and compositions for use in the method |
| 05/13/2009 | EP1565429B1 Diaryl ureido derivatives and their medical use |
| 05/12/2009 | US7531668 2-arylcarboxamide-nitrogenous heterocycle compound |
| 05/12/2009 | US7531576 N-alkyl-N-(p-substituted-phenyl)benzylamine that is N-substituted with carbocyclic aminocarbonylalkylene, aminocarbonyl, or aminocarbonylaminosulfonyl; ACAT inhibitors; treating e.g.,hypercholesterolemia and atherosclerosis |
| 05/07/2009 | WO2009056582A1 Novel compounds |
| 05/07/2009 | US20090118502 organic or inorganic salt of N-{3-[4'-(4-Aminomethyl-[1,2,3]triazol-1-ylmethyl)-2-fluoro-biphenyl- 4-yl]-2-oxo-oxazolidin-5-(S)-ylmethyl}-acetamide; anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents |
| 05/07/2009 | US20090117042 Imaging agents and methods of imaging NAALADase or PSMA |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | EP1343770B1 Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/05/2009 | US7528258 Trityl olmesartan medoxomil is reacted with an acid in a water miscible organic solvent, separating the precipitate of triphenyl carbinol from the solution of olmesartan medoxomil; solution of olmesartan medoxomil is treated with a base to obtain a precipitate of olmesartan medoxomil |
| 05/05/2009 | US7528257 Reacting dimethyl-malononitrile with sodium azide and zinc bromide; cooling to room temperature producing Bis(N-ethanol-5-tetrazolyl)propane, purifying the di-tetrazole by recrystallization in a second solvent; for making energetic urethane cured binders by using di-tetrazoles; for use in pyrotechnics |
| 04/30/2009 | WO2009054479A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | WO2007119246A3 An improved process for the manufacture of losartan potassium |
| 04/30/2009 | US20090111995 Process for the manufacture valsartan |
| 04/30/2009 | US20090111994 Method for The Production of Losartan |
| 04/30/2009 | US20090111861 Phthalamide Derivative, Agricultural or Horticultural Pesticide, and Use of the Pesticide |
| 04/30/2009 | US20090111857 1,2,4-triazole ether derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111854 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111799 Anti-infective agents against intracellular pathogens |
| 04/30/2009 | US20090111730 Polypeptide protracting tags |
| 04/30/2009 | CA2704013A1 Spiro-ring compound and use thereof for medical purposes |
| 04/29/2009 | EP1786475B1 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 04/29/2009 | EP1765812B1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 04/29/2009 | CN101417964A Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 04/28/2009 | US7524872 Tetrazolium salts and derivatives, preferably tetrazolium red and tetrazolium violet, in combination with chemotherapeutic agents delivered in a polylactic acid carrier; noninvasive antitumor treatments |
| 04/23/2009 | WO2009052078A1 Ccr10 antagonists |
| 04/23/2009 | WO2009025914A3 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 04/23/2009 | US20090105322 Pharmaceutical composition comprising valsartan |
| 04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
| 04/23/2009 | US20090104151 Smac mimetic dimers and trimers useful as anti-cancer agents |
| 04/23/2009 | CA2702469A1 Ccr10 antagonists |
| 04/22/2009 | EP2049467A2 Therapeutic amides and related compounds |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | CN101415693A Metal complex and use thereof |
| 04/21/2009 | US7521480 Such as 2-[3-(3-Bromo-phenyl)-ureido]-4-chloro-5-methyl-benzenesulfonic acid which is selective and non-competitive antagonist of ionotropic GluR5 receptor |
| 04/16/2009 | WO2009049305A2 5- (2-hydroxyphenyl) tetrazoles as hsp90 inhibitors against cancer |
| 04/16/2009 | WO2007005058A3 Monoazole ligand platinum analogs |
| 04/16/2009 | WO2003082205A3 Compounds and methods |
| 04/16/2009 | US20090099241 Pharmaceutical composition containing antihypertensive agents |
| 04/16/2009 | CA2700893A1 Substituted tetrazole compounds and uses thereof |
| 04/15/2009 | EP1703909B1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 04/15/2009 | EP1244648B1 Chemokine receptor binding heterocyclic compounds |
| 04/14/2009 | US7517998 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus |